CFAP96 and familial pancreatic carcinoma: Because PTX is an anticancer drug that is widely administered in Japan to treat pancreatic cancer that cannot be curatively resected 52 and its mechanism of action is to inhibit microtubule depolymerization 53-55, we hypothesized that PTX might have some interaction with C4orf47 as it is a centrosome-associated protein.